Page 35 - Sun Pharma News Today

Top gainers on the Nifty 50 included Bajaj Finserv, Nestle India, Apollo Hospital Enterprises, Cipla, and Sun Pharma.

Nifty Bank index which comprises data of 12 banking stocks, tanked by 507.95 points or 1.06 per cent to finish at 47,327.85.

Nifty on Monday fell 161 points to form a bearish Engulfing pattern on the daily charts to hint at short-term top reversal for the market. The short-term trend of Nifty seems to have turned down and the next lower levels to be watched are around 22,100-22,050 levels.

Sun Pharma is recalling 55,000 bottles of Febuxostat Tablets, in 40 mg and 80 mg strengths, from the American market due to manufacturing practice deviations caused by microbial contamination at their Dadra-based plant.

"22,250-22,200 is likely to be seen as intermediate support, followed by the strong support of 22,150 and finally, the psychological mark of 22,000 from a broader term view. On the higher end, finding resilience is challenging in uncharted territory, though 22,600-22,650 could be seen as the following potent targets for Nifty in the upcoming week," said Osho Krishan, Angel One.

Sun Pharma recalls Febuxostat Tablets in 40 mg and 80 mg strengths from US market.

The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

Drug major Sun Pharma is recalling around 55,000 bottles of a generic medication to treat gout from the American market due to manufacturing practices norms deviations, according to the US health regulator. The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in

Cipla, Apollo Hospital, Infosys, HCL Tech and Sun Pharma were among the top losers on NSE.

Sensex Today: Get the latest updates on the stock market as Sensex surges by 1,000 points, propelling Nifty to an all-time high. Explore the five key reasons behind Friday's remarkable market rally at news18.